Daniel Stewart, DO
Dermatology · Clinton Township, MINPI 1881699676
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,500 of the $3,314 with a category attached, or 75.4%. AbbVie accounts for 78.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $2,560 and has fallen 96.8% since, to $82 in 2025. That places this record below the midpoint for dermatology clinicians in MI, where the typical reported total is $2,933.
Across 41 payments — averaging $80.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$109
- UCB, Inc.$108
- Sanofi$99
- Novartis$67
- Boehringer Ingelheim$54
- plus $271 from 11 others
Across 238 payments — averaging $2693.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aclaris Therapeutics, Inc.$188K
- Bausch Health US, LLC$130K
- E.r. Squibb & Sons, L.L.C.$119K
- AbbVie$76K
- Kiniksa Pharmaceuticals, Ltd.$40K
- Pfizer$34K
- plus $55K from 7 others
What the payments were for
- Speaking & faculty fees$2,50075%
- Food & beverage$72922%
- Education$853%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $2,606 |
| Johnson & Johnson | 3 | $109 |
| UCB, Inc. | 3 | $108 |
| Sanofi | 5 | $99 |
| Novartis | 3 | $67 |
| Boehringer Ingelheim | 2 | $54 |
| VYNE Pharmaceuticals Inc. | 2 | $48 |
| Esperion Therapeutics, Inc. | 1 | $38 |
| Pfizer | 5 | $37 |
| Prugen, Inc. Pharmaceuticals | 2 | $33 |
| Incyte Corporation | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Journey Medical Corporation | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
| EPI Health, LLC | 1 | $11 |
How this compares
$3,314 in reported general payments places this provider in the 50th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $40,754 |
| Clobetasol Propionate | 60 | $1,717 |
| Fluorouracil | 23 | $1,252 |
| Econazole Nitrate | 47 | $1,197 |
| Mupirocin | 142 | $849 |
| Metronidazole | 15 | $353 |
| Ketoconazole | 31 | $335 |
| Hydrocortisone | 54 | $295 |
| Triamcinolone Acetonide | 44 | $184 |
| Cephalexin | 16 | $150 |
| Doxycycline Hyclate | 15 | $60 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Clinton Township
- Davide IacobelliClinton Township$240K
- Tiffany CukrowskiClinton Township$36K
- Linda Stein GoldWest Bloomfield$3.3M
- Kristi HawleyCaledonia$2.2M
- David AltmanWarren$1.9M
- Michael SiegelWaterford$708K
- Johann GudjonssonAnn Arbor$535K
- Michael DormanWest Bloomfield$433K
- Steven DaveluyDearborn$350K
- Benjamin WorkmanMidland$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.